Genomics England is today inviting applications to join our new Clinical Interpretation Partnership from UK researchers, NHS Clinicians and those in training where they will work on the unique data resource from the 100,000 Genomes Project. The goal of the Genomics England Clinical Interpretation Partnership (GeCIP) is to bring together the best researchers in the UK alongside their key international collaborators to ensure we maximise the potential of gaining new biological insights into rare inherited diseases,
Genomics England, the company leading the UK’s 100,000 Genomes Project, has released details of those companies that distinguished themselves in its annotation assessment exercise. Genomics England is committed to kick-starting the development of a UK genomics industry and this assessment exercise is part of that aim, as well as to evaluate and select potential service providers for the 100,000 Genomes Project.
Genomics England sent an Annotation Assessment Questionnaire to twenty eight participants together with the BAM and Variant Call Format files in respect of ten cancer/normal samples and fifteen rare disease trio samples in February 2014.
UK to become world number one in DNA testing with plan to revolutionise fight against cancer and rare diseases
The UK is set to become the world leader in ground-breaking genetic research into cancer and rare diseases, which will transform how diseases are diagnosed and treated, thanks to a package of investment worth more than £300million, the Prime Minister will announce today.
The four year project will allow scientists to do pioneering new research to decode 100,000 human genomes – a patient’s personal DNA code. The landmark project is on a scale not seen anywhere else in the world and is part of the Prime Minister’s commitment to ensure the NHS as well as the UK’s research and life science sector is at the forefront of global advances in modern medicine.
Businesses are being offered a share of £10 million to develop cutting edge technology to analyse and better interpret significant variations in the DNA of NHS patients with serious illnesses.
The Department of Health and Genomics England are inviting innovators to develop high-tech software products that will support its goal to sequence and better understand genomes for NHS patients with cancer and rare inherited diseases.
Developments in computer software could improve the reports to NHS doctors and the feedback they give to patients of what whole genome sequencing has found,
The government’s major drive to introduce high-tech DNA mapping for patients will start by tackling cancer, rare diseases and infectious diseases, Health Secretary Jeremy Hunt announced today, the NHS’ 65th birthday, alongside plans to make the NHS a personal service for every patient.
In December Prime Minister David Cameron announced that the personal DNA code – known as a genome – of up to 100,000 patients or infections in patients will be sequenced over the next five years.